The primary end point was the reduction in the percentage of subjects with clinically symptomatic respiratory illness, defined as illness associated with a respiratory tract infection based on prespecified diagnostic criteria, with or without laboratory confirmation of a pathogen.
More than 1,600 Americans have now been struck by a severe, sometimes fatal, lung illness tied to vaping.
Gefapixant has demonstrated efficacy in improving objective cough frequency and quality of life among individuals with chronic cough.
Nearly one-third of patients with cystic fibrosis-related hospitalizations have aspergillosis, which is associated with worse outcomes.
Patients with established chronic lung allograft dysfunction may have a higher risk for respiratory syncytial virus infections, but lung function decline does not appear to be significantly affected.
Data revealed many healthcare personnel who reported an illness said they worked when sick.
Lefamulin appears to be noninferior in safety and efficacy compared with moxifloxicin in the treatment of community-acquired bacterial pneumonia.
Walking by display of hot tubs is the likely source of disease, state health officials say.